Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel
LON:NIOX

NIOX Group 9/30/2025 Earnings Report

NIOX Group logo
GBX 58.70 +0.30 (+0.51%)
As of 05/29/2026 12:06 PM Eastern
ProfileEarnings HistoryForecast

NIOX Group EPS Results

Actual EPS
GBX 1.43
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NIOX Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NIOX Group Announcement Details

Quarter
Date
9/30/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NIOX Group Earnings Headlines

NIOX Group PLC NIOX
May 12, 2026  |  morningstar.comM
NIOX GROUP PLC by NIOX GROUP PLC Stock (OTC:CSSPF), Trade Ideas
April 22, 2026  |  benzinga.comhttps://www.benzinga.com/quote/CSSPF/ideas
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
May 31 at 1:00 AM  |  Weiss Ratings (Ad)
Top UK Penny Stocks To Watch In March 2026
March 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/top-uk-penny-stocks-watch-140540708.html
3 UK Stocks Estimated To Be Up To 43.4% Below Intrinsic Value
March 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/3-uk-stocks-estimated-43-063828274.html
Niox raises dividend as profit climbs in "another excellent year"
March 24, 2026  |  lse.co.ukhttps://www.lse.co.uk/news/niox-raises-dividend-as-profit-climbs-in-another-excellent-year-ulvq096qjqh79mb.html
See More NIOX Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NIOX Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NIOX Group and other key companies, straight to your email.

About NIOX Group

NIOX Group (LON:NIOX) is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings. Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries. NIOX is committed to enabling more precise and personalised care for patients with respiratory conditions, with a focus on quality, innovation, and scientific excellence.

View NIOX Group Profile
Earnings Tools